Genetic Disorder News and Research

RSS
Researchers successfully use CRISPR to treat adult mouse model of Duchenne muscular dystrophy

Researchers successfully use CRISPR to treat adult mouse model of Duchenne muscular dystrophy

3D maps of spatial organization may help find genes involved in hereditary diseases

3D maps of spatial organization may help find genes involved in hereditary diseases

New $8.5M research grant aims to address patients affected by severe hemophilia A

New $8.5M research grant aims to address patients affected by severe hemophilia A

New study reveals why some vestibular schwannomas cause hearing loss

New study reveals why some vestibular schwannomas cause hearing loss

Case Western scientist to lead a pair of studies to develop more effective treatment for CF

Case Western scientist to lead a pair of studies to develop more effective treatment for CF

Report uncovers how Down syndrome hampers nervous system that plays key role in health, longevity

Report uncovers how Down syndrome hampers nervous system that plays key role in health, longevity

Commercialization of health and beauty can lead to Angelina Jolie syndrome

Commercialization of health and beauty can lead to Angelina Jolie syndrome

CRISPR/Cas9 turns hPSCs into cell-based lab model system for polycystic kidney disease

CRISPR/Cas9 turns hPSCs into cell-based lab model system for polycystic kidney disease

ASU-led researchers add new worldwide resource to explore genes' deep and hidden messages

ASU-led researchers add new worldwide resource to explore genes' deep and hidden messages

New biobank initiative may help unlock some of the mysteries linked to Down syndrome

New biobank initiative may help unlock some of the mysteries linked to Down syndrome

Sex differences in the brain may provide clues to why certain forms of autism more common in males

Sex differences in the brain may provide clues to why certain forms of autism more common in males

Flagship launches Rubius to develop functionalized red blood cells for treatment of serious diseases

Flagship launches Rubius to develop functionalized red blood cells for treatment of serious diseases

Kanuma approved as first treatment for patients with LAL deficiency

Kanuma approved as first treatment for patients with LAL deficiency

Existing compound offers hope for slowing Huntington's disease progression

Existing compound offers hope for slowing Huntington's disease progression

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Experimental gene therapy may improve health outcomes for patients with some forms of blood disorders

Neoadjuvant chemotherapy can stimulate evolution of breast cancer tumor

Neoadjuvant chemotherapy can stimulate evolution of breast cancer tumor

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

Green Cross' Biologics License Application for IVIG-SN submitted to FDA

U of T researchers discover mysterious fungus that defends against neighbouring bacteria

U of T researchers discover mysterious fungus that defends against neighbouring bacteria

MCG researchers explore how neurofibromatosis puts young patients at risk for cardiovascular disease

MCG researchers explore how neurofibromatosis puts young patients at risk for cardiovascular disease

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.